
Pharmacovigilance rules updated by ANVISA
The Brazilian National Health of Surveillance Agency (ANVISA) published on July 29, 2020 the Resolution RDC No. 406/2020 and Normative Instruction – IN No. 63/2020 in order to update the regulations on pharmacovigilance. The new regulatory framework is the result of an extensive discussion between ANVISA and the industry through public consultations. Both RDC No. […]